on Asklepios Kliniken (isin : DE000A0ETLQ3)
Asklepios Group Reports Continued Positive Development in First Half of 2024
Asklepios Kliniken has announced successful financial results for the first half of 2024. The group's consolidated revenue soared to EUR 2,902.6 million, marking a 7.2% increase compared to the previous year's EUR 2,708.4 million. The net interim income after taxes for this period grew to EUR 74.1 million, significantly higher than last year's EUR 45.6 million.
The group treated 1,818,146 patients in the first six months, reflecting a steady demand for medical care. Investments also remained robust at EUR 150.5 million. Asklepios maintains a competitive position in Germany's evolving healthcare landscape, despite economic challenges.
With integrated cooperation with MEDICLIN and RHÖN, Asklepios continues to enhance its operational efficiency. CEO Joachim Gemmel praised the group's resilience and commitment to advancing medical quality and innovation. The future outlook remains cautiously optimistic amid regulatory and economic uncertainties.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Asklepios Kliniken news